| Literature DB >> 30364338 |
Carme Uribe1, Barbara Segura1,2, Hugo C Baggio1, Anna Campabadal1, Alexandra Abos1, Yaroslau Compta2,3,4, Maria Jose Marti2,3,4, Francesc Valldeoriola2,3,4, Nuria Bargallo5, Carme Junque1,2,3.
Abstract
Hippocampal subfields have different vulnerability to the degenerative processes related to aging, amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD), but the temporal evolution in Parkinson's disease (PD) is unknown. The purposes of the current work are to describe regional hippocampal changes over time in a sample of PD patients classified according to their baseline cognitive status and to relate these changes to verbal memory loss. T1-weighted images and verbal memory assessment were obtained at two separate time points (3.8 ± 0.4 years apart) from 28 PD with normal cognition (PD-NC), 16 PD with MCI (PD-MCI) and 21 healthy controls (HCs). FreeSurfer 6.0 automated pipeline was used to segment the hippocampus into 12 bilateral subregions. Memory functions were measured with Rey's Auditory Verbal learning test (RAVLT). We found significant reductions in cornu ammonis 1 (CA1) over time in controls as well as in PD subgroups. Right whole-hippocampal volumes showed time effects in both PD groups but not in controls. PD-NC patients also displayed time effects in the left hippocampal tail and right parasubiculum. Regression analyses showed that specific hippocampal subfield volumes at time 1 predicted almost 60% of the variability in RAVLT delayed-recall score decline. Changes in several hippocampal subregions also showed predictive value for memory loss. In conclusion, CA1 changes in PD were similar to those that occur in normal aging, but PD patients also had more decline in both anterior and posterior hippocampal segments with a more pronounced atrophy of the right hemisphere. Hippocampal segments are better predictors of changes in memory performance than whole-hippocampal volumes.Entities:
Keywords: MRI; Parkinson’s disease; aging; hippocampal subfields; longitudinal assessment; memory impairment
Year: 2018 PMID: 30364338 PMCID: PMC6193198 DOI: 10.3389/fnagi.2018.00325
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Coronal and sagittal view of the 12 bilateral segments in which the hippocampus was automatically segmented as described by Iglesias et al. (2015). Abbreviations: CA, cornu ammonis; GC-DG, granule cells in the molecular layer of the dentate gyrus; HATA, hippocampal amygdala transition area; HP_tail, hippocampal tail.
Demographic and clinical characteristics of the sample at both times.
| PD-NC | PD-MCI | PD whole sample | Controls | Test stats | ||
|---|---|---|---|---|---|---|
| Time 1 | 59.0 (11.8) | 61.5 (17.3) | 60.0 (10.5) | 67.0 (13.0) | 0.0441 | |
| Time 2 | 63.5 (12.5) | 66.0 (15.8) | 64.5 (12.0) | 70.0 (12.0) | 0.0551 | |
| Education, years, median (IQ range) | 13.0 (8.3) | 10.0 (7.5) | 12.0 (8.3) | 10.0 (7.0) | 0.4531 | |
| Sex, female, | 8 (28.6) | 6 (37.5) | 14 (31.8) | 10 (47.6) | X2 = 1.8721 | 0.3921 |
| Time 1 | 6.0 (5.0) | 6.0 (9.5) | 6.0 (7.5) | NA | 0.759 | |
| Time 2 | 9.0 (4.0) | 8.0 (8.3) | 9.0 (6.3) | NA | 0.565 | |
| Age of onset, years, median (IQ range) | 53.5 (15.8) | 55.3 (15.8) | 54.0 (15.8) | NA | 0.294 | |
| Time 1 | 11/1/12/2/2/0 | 6/0/8/1/1/0 | 17/1/20/3/3/0 | NA | X2 = 0.718 | 0.949 |
| Time 2 | 3/0/14/0/11/0 | 3/0/5/0/7/1 | 6/0/19/0/18/1 | NA | X2 = 3.111 | 0.375 |
IQ range, interquartile range; NA, not applicable; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition. P-values are from Kruskal-Wallis test followed by Mann-Whitney pairwise test and Bonferroni correction for continuous variables and chi-squared test for categorical variables. .
Repeated clinical measures.
| PD-NC | PD-MCI | PD all sample | Controls | Time effects | ||||
|---|---|---|---|---|---|---|---|---|
| PD-NC | PD-MCI | PD all sample | Controls | |||||
| Time 1 | 29.5 (0.7) | 28.7 (1.5) | 29.2 (1.1) | 29.8 (0.4) | ||||
| Time 2 | 29.1 (1.0) | 27.6 (3.4) | 28.6 (2.3) | 29.3 (0.9) | ||||
| Time 1 | 13.9 (9.2) | 11.8 (11.0) | 13.1 (9.8) | NA | NS | NA | ||
| Time 2 | 17.8 (9.0) | 17.4 (12.7) | 17.7 (10.3) | NA | ||||
| Time 1 | 700.8 (470.6) | 675.6 (535.2) | 691.6 (489.0) | NA | NS | NS | NS | NA |
| Time 2 | 720.5 (388.2) | 693.3 (481.1) | 710.6 (419.0) | NA | ||||
| Time 1 | 7.3 (4.9) | 11.1 (6.3) | 8.7 (5.7) | 7.0 (5.4) | NS | NS | NS | |
| Time 2 | 8.5 (7.4) | 10.0 (6.3) | 9.1 (7.0) | 5.3 (4.7) | ||||
| Time 1 | 10.6 (5.7) | 14.3 (8.7) | 11.9 (7.0) | 9.1 (5.6) | NS | NS | NS | NS |
| Time 2 | 11.4 (6.6) | 14.1 (9.4) | 12.4 (7.7) | 9.3 (5.6) | ||||
| Time 1 | 4.5 (7.2) | 9.1 (11.8) | 6.2 (9.3) | 1.9 (3.6) | NS | |||
| Time 2 | 7.1 (8.8) | 13.1 (11.6) | 9.3 (10.2) | 2.3 (2.6) | ||||
LEDD, L-DOPA equivalent daily dose; NA, not applicable; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition; SD, standard deviation; UPDRS part III, Unified Parkinson’s Disease Rating Scale motor section. NS, non-significant. *P-values < 0.05 after Bonferroni correction.
Time effects and group-by-time interaction for significant hippocampal segments.
| Time effects | Interaction time × group | |||||||
|---|---|---|---|---|---|---|---|---|
| PD-NC | PD-MCI | PD all sample | Controls | HC > PD-NC | HC > PD-MCI | PD-NC > PD-MCI | HC > PD all sample | |
| Left hippocampal tail | NS | NS | ||||||
| Right CA1 | ||||||||
| Right parasubiculum | NS | NS | ||||||
| Right whole hippocampus | NS | |||||||
CA, Cornu Ammonis; HC, healthy controls; NS, non-significant; PD-MCI, Parkinson’s disease mild cognitive impairment; PD-NC, Parkinson’s disease normal cognition.
Repeated measures analysis of memory performance.
| PD-NC | PD-MCI | PD all sample | Controls | Time effects | ||||
|---|---|---|---|---|---|---|---|---|
| PD-NC | PD-MCI | PD all sample | Controls | |||||
| Time 1 | 0.14 (1.12) | −1.52 (0.80) | −0.47 (1.29) | 0.00 (0.81) | NS | NS | ||
| Time 2 | −0.58 (1.30) | −1.66 (1.25) | −0.97 (1.37) | −0.06 (0.73) | ||||
| Time 1 | −0.15 (1.12) | −1.30 (0.94) | −0.57 (1.19) | 0.06 (0.90) | NS | NS | NS | |
| Time 2 | −0.46 (1.38) | −1.70 (1.10) | −0.91 (1.41) | −0.04 (0.74) | ||||
| Time 1 | 0.20 (1.04) | −0.95 (2.23) | −0.22 (1.65) | −0.17 (0.76) | NS | NS | ||
| Time 2 | −1.38 (2.85) | −1.76 (1.86) | −1.51 (2.52) | 0.01 (0.94) | ||||
NS, not significant; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition; RAVLT, Rey’s auditory verbal learning test. Means are adjusted z-scores by age, years of education and sex. *Indicates statistical significance (P-values < 0.05) after Bonferroni correction.